SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's recalling over 8,000 bottles of generic drug in US due to a packaging error

08 Jan 2024 Evaluate

Dr Reddy's Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error. The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for ‘presence of foreign tablets/capsules’ in the affected lot. One 0.5 mg Tacrolimus capsule was found in a bottle of 1 mg Tacrolimus capsules. The affected lot was produced at Dr Reddy's Bachupally-based plant near Hyderabad.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1291.05 19.50 (1.53%)
22-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.45
Dr. Reddys Lab 1291.05
Cipla 1415.30
Zydus Lifesciences 1084.35
Lupin 2339.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: